Search

Burwick, Richard M., Sigal Yawetz, Kathryn E. Stephenson-, -Rebecca Zash, and William R. Short. 2021. “Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019”. Clinical Infectious Diseases 73 (11): e3996-e4004.

Stephenson, Kathryn E., Chen Sabrina Tan, Stephen R. Walsh-, -Kayvon Modjarrad, and Dan H. Barouch. 2020. “Safety and Immunogenicity of a Zika Purified Inactivated Virus Vaccine Given via Standard, Accelerated, or Shortened Schedules: A Single-Centre, Double-Blind, Sequential-Group, Randomised, Placebo-Controlled, Phase 1 Trial”. Lancet Infectious Diseases 20 (9): 1061-70.

Stephenson, Kathryn E., Jasmine R. Marcelin, Audrey E. Pettifor-, -Lawrence Corey, and James G. Kublin. 2023. “Efficacy of Messenger RNA–1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021”. Open Forum Infectious Diseases 10 (11): ofad511.

Banga, Jaspreet, Taylor Brock-Fisher, Brittany A. Petros-, -Pardis C. Sabeti, and Kathryn E. Stephenson. 2024. “Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission During the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study Using Genomic Epidemiology”. MedRxiv.

Salisch, Nadine C., Kathryn E. Stephenson, Kristi Williams-, -Hanneke Schuitemaker, and Dan H. Barouch. 2021. “A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine”. Annals of Internal Medicine 714 (5): 585-94.

Stephenson, Kathryn E., Kshitij Wagh, Bette Korber, and Dan H. Barouch. 2020. “Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention”. Annual Reviews Immunology 98: 673-703.

Julg, Boris, Kathryn E. Stephenson, Frank Tomaka, Stephen R. Walsh, Sabrina Tan, Ludo Lavreys-, -Hanneke Schuitemaker, and Dan H. Barouch. 2024. “Immunogenicity of 2 Therapeutic Mosaic HIV-1 Vaccine Strategies in Individuals With HIV-1 on Antiretroviral Therapy”. NPJ Vaccines 9.